Demonstration of human T lymphotropic virus type I (HTLV-I)-specific T cell responses from seronegative and polymerase chain reaction-negative persons exposed to HTLV-I. 1994

M Nishimura, and A G Kermode, and M Clerici, and G M Shearer, and J A Berzofsky, and T Uchiyama, and S Z Wiktor, and E Pate, and B Maloney, and A Manns
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892.

Human T lymphotropic virus type I (HTLV-I) is a human retrovirus etiologically linked to adult T cell leukemia and the progressive chronic neurologic disease HTLV-I-associated myelopathy/tropical spastic paraparesis. Described is a method that measures the production of interleukin-2 from HTLV-I synthetic peptide-stimulated peripheral blood lymphocytes (PBL) of HTLV-I-infected persons. The peptides correspond to immunogenic regions of the HTLV-I Env and Tax proteins. Significantly, this assay demonstrated T cell responses to these HTLV-I peptides from coded PBL samples in 7 of 19 HTLV-I-seronegative polymerase chain reaction-negative persons known to have been exposed to HTLV-I but in none of 16 matched controls without risk factors for exposure (P = .007). The implications of this finding are discussed.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence

Related Publications

M Nishimura, and A G Kermode, and M Clerici, and G M Shearer, and J A Berzofsky, and T Uchiyama, and S Z Wiktor, and E Pate, and B Maloney, and A Manns
February 1996, Multiple sclerosis (Houndmills, Basingstoke, England),
M Nishimura, and A G Kermode, and M Clerici, and G M Shearer, and J A Berzofsky, and T Uchiyama, and S Z Wiktor, and E Pate, and B Maloney, and A Manns
June 1992, Journal of clinical microbiology,
M Nishimura, and A G Kermode, and M Clerici, and G M Shearer, and J A Berzofsky, and T Uchiyama, and S Z Wiktor, and E Pate, and B Maloney, and A Manns
December 1993, Annals of neurology,
M Nishimura, and A G Kermode, and M Clerici, and G M Shearer, and J A Berzofsky, and T Uchiyama, and S Z Wiktor, and E Pate, and B Maloney, and A Manns
January 1995, Journal of virological methods,
M Nishimura, and A G Kermode, and M Clerici, and G M Shearer, and J A Berzofsky, and T Uchiyama, and S Z Wiktor, and E Pate, and B Maloney, and A Manns
June 1991, Blood,
M Nishimura, and A G Kermode, and M Clerici, and G M Shearer, and J A Berzofsky, and T Uchiyama, and S Z Wiktor, and E Pate, and B Maloney, and A Manns
March 1996, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society,
M Nishimura, and A G Kermode, and M Clerici, and G M Shearer, and J A Berzofsky, and T Uchiyama, and S Z Wiktor, and E Pate, and B Maloney, and A Manns
August 1993, Transfusion,
M Nishimura, and A G Kermode, and M Clerici, and G M Shearer, and J A Berzofsky, and T Uchiyama, and S Z Wiktor, and E Pate, and B Maloney, and A Manns
February 1990, Medicina clinica,
M Nishimura, and A G Kermode, and M Clerici, and G M Shearer, and J A Berzofsky, and T Uchiyama, and S Z Wiktor, and E Pate, and B Maloney, and A Manns
January 2000, The Journal of emergency medicine,
M Nishimura, and A G Kermode, and M Clerici, and G M Shearer, and J A Berzofsky, and T Uchiyama, and S Z Wiktor, and E Pate, and B Maloney, and A Manns
February 2004, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!